Shrishivay Sankatmochan Pharma Profile
Key Indicators
- Authorised Capital ₹ 1.00 M
as on 18-07-2024
- Paid Up Capital ₹ 1.00 M
as on 18-07-2024
- Company Age 6 Year, 5 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 5.03 Cr
as on 18-07-2024
- Revenue -14.88%
(FY 2023)
- Profit 0.89%
(FY 2023)
- Ebitda -19.28%
(FY 2023)
- Net Worth 25.26%
(FY 2023)
- Total Assets 14.25%
(FY 2023)
About Shrishivay Sankatmochan Pharma
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 1.00 M and a paid-up capital of Rs 1.00 M.
The company currently has active open charges totaling ₹5.03 Cr.
Balaram Pandey, Gopal Pandey, Savita Pandey, and One other member serve as directors at the Company.
- CIN/LLPIN
U85100UP2018PTC106287
- Company No.
106287
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
17 Jul 2018
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Kanpur
Industry
Company Details
- Location
Varanasi, Uttar Pradesh, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Shrishivay Sankatmochan Pharma?
Board Members(4)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Balaram Pandey  | Director | 17-Jul-2018 | Current |
| Gopal Pandey | Director | 17-Jul-2018 | Current |
| Savita Pandey | Director | 17-Jul-2018 | Current |
| Satyprakash Rai | Director | 24-Oct-2018 | Current |
Financial Performance of Shrishivay Sankatmochan Pharma.
Shrishivay Sankatmochan Pharma Private Limited, for the financial year ended 2023, experienced significant reduction in revenue, with a 14.88% decrease. The company also saw a slight improvement in profitability, with a 0.89% increase in profit. The company's net worth Soared by an impressive increase of 25.26%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Shrishivay Sankatmochan Pharma?
In 2023, Shrishivay Sankatmochan Pharma had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Wellduphargrand Healthcare Private LimitedActive 6 years 2 monthsBalaram Pandey, Gopal Pandey and 1 more are mutual person
- Primeshreya Remedies Private LimitedActive 6 years 2 months
Balaram Pandey, Gopal Pandey and 1 more are mutual person
- Solvy Remedies Private LimitedActive 6 years 6 months
Balaram Pandey, Gopal Pandey and 1 more are mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Hdfc Bank Limited Creation Date: 09 Oct 2019 | ₹5.03 Cr | Open |
How Many Employees Work at Shrishivay Sankatmochan Pharma?
Unlock and access historical data on people associated with Shrishivay Sankatmochan Pharma, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Shrishivay Sankatmochan Pharma, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Shrishivay Sankatmochan Pharma's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
